newsfilter
← Latest News
GlobeNewswire·

BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million

Proceeds to support advancement of BX004 program through Phase 2b study topline results in cystic fibrosis (CF) patients, anticipated in Q1 2026 Financing will also support analysis of real-world evidence in people